Tag: cognitive diagnostics market size

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Cognitive Diagnostics Market Size Forecast: How Large Could The Market Become By 2030?

The cognitive diagnostics market has experienced substantial expansion, with projections indicating a rise from a valuation of $6.25 billion in 2025 to $7.69 billion by 2026, reflecting a commanding compound annual growth rate of 23.1%. This remarkable growth trajectory has been propelled by several key factors, including the escalating incidence of neurodegenerative diseases, a heightened societal focus on maintaining cognitive well-being, advancements in diagnostic imaging technologies, the increasing utilization of uniform cognitive assessment tools, and the proliferation of specialized neurology clinics.

In the realm of cognitive diagnostics, a period of substantial expansion is anticipated in the ensuing years, with the market poised to reach a valuation of $17.46 billion by the year 2030. This impressive trajectory is underpinned by a compound annual growth rate (CAGR) of 22.7%, propelled by several key factors including escalating investments directed towards digital diagnostic solutions, a heightened demand for the identification of cognitive disorders in their nascent stages, the proliferation of assessment tools designed for at-home use, the increasing incorporation of artificial intelligence into clinical decision-making processes, and a pronounced emphasis on tailored cognitive care strategies. Furthermore, prevailing trends shaping this forecast period encompass the growing utilization of AI-powered cognitive assessment instruments, the wider adoption of digital platforms for cognitive screening, a greater deployment of neuroimaging analytics, the expansion of remote cognitive testing capabilities, and an intensified focus on the early detection of diseases.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19373&type=smp

#Cognitive Diagnostics Market Growth Drivers And Industry Catalysts

The burgeoning rates of neurological conditions are poised to act as a significant catalyst for the expansion of the cognitive diagnostics market. These neurological conditions, which impact the brain, spinal cord, and the broader nervous system, lead to functional impairments manifesting as cognitive deterioration, difficulties with motor control, and unusual sensory experiences. A primary factor fueling this increase is the higher occurrence of age-associated ailments, notably Alzheimer’s and Parkinson’s disease. In addition to genetic predispositions, environmental pollutants, elevated stress levels, poor dietary habits, and inactive lifestyles also play a role in the growing prevalence of these disorders. Within the realm of neurological diseases, cognitive diagnostics serve a crucial role in evaluating, identifying, and tracking impairments in cognitive function, thereby facilitating early detection and effective management of conditions such as Alzheimer’s and Parkinson’s. Illustratively, the Alzheimer’s Association, a U.S. nonprofit supporting Alzheimer’s care, assistance, and research, reported in May 2024 that the count of Americans aged 65 and over living with Alzheimer’s dementia climbed from 6.5 million in 2022 to an estimated 6.9 million in 2024. Consequently, the escalating incidence of neurological disorders is directly fostering the growth of the cognitive diagnostics market.

Cognitive Diagnostics Market Segment Analysis: What Are The Major Market Categories?

The cognitive diagnostics market covered in this report is segmented –

1) By Diagnosis: Brain Imaging Tests, Laboratory Testing, Mental Status Testing, Rapid Home Screening Tests, Neuropsychological Testing, Electroencephalogram (EEG), Cognitive Function And Behavioral Tests, Neuropsychiatric Inventory Questionnaire (NPI-Q)

2) By Indication: Alzheimer’s Disease, Attention Deficit Or Hyperactivity Disorder, Dementia, Epilepsy-Related Cognitive Dysfunction, Mild Cognitive Impairment, Parkinson’s Disease-Related Cognitive Dysfunction, Stroke-Related Cognitive Dysfunction, Traumatic Brain Injury, Other Indications

3) By End User: Hospitals, Neurology Clinics, Cognitive Behavioral Therapy Centers, Rehabilitation Centers, Academic And Research Institutes, Diagnostic Imaging Centers, Home Care Settings

Subsegments:

1) By Brain Imaging Tests: Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Computed Tomography (CT) Scans, Functional MRI (fMRI), Single-Photon Emission Computed Tomography (SPECT), Magnetoencephalography (MEG)

2) By Laboratory Testing: Blood Biomarkers for Cognitive Disorders, Genetic Testing for Cognitive Impairment, CSF (Cerebrospinal Fluid) Biomarker Tests, Hormonal and Metabolic Testing, Genetic Sequencing for Alzheimer’s Disease

3) By Mental Status Testing: Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Saint Louis University Mental Status (SLUMS) Exam, Cognitive Assessment Screening Tools

4) By Rapid Home Screening Tests: Self-Administered Cognitive Tests, Mobile App-Based Cognitive Screening, At-Home Memory and Mental Health Tests

5) By Neuropsychological Testing: Cognitive and Behavioral Assessment Batteries, Attention and Memory Function Tests, Executive Function and Problem-Solving Tests, Verbal and Visual Learning Tests

6) By Electroencephalogram (EEG): Resting-State EEG for Cognitive Disorders, Event-Related Potential (ERP) Testing, Quantitative EEG (QEEG) for Brain Mapping, Long-Term EEG Monitoring for Cognitive Disorders

7) By Cognitive Function and Behavioral Tests: Memory Function Tests, Attention and Concentration Tests, Language and Communication Tests, Mood and Behavior Assessments

8) By Neuropsychiatric Inventory Questionnaire (NPI-Q): NPI-Q for Dementia Screening, Behavioral and Psychological Symptoms of Dementia (BPSD) Assessment, NPI-Q for Alzheimer’s Disease and Other Cognitive Disorders, Shortened Versions of NPI-Q for Clinical Settings.

#Cognitive Diagnostics Market Trends Influencing Long-Term Demand

Leading entities within the cognitive diagnostics sector are prioritizing the delivery of immediate understandings of cognitive well-being, leveraging innovations in diagnostic instruments like neuropsychological testing platforms to elevate the precision, effectiveness, and completeness of cognitive evaluations. These advanced neuropsychological testing platforms serve as sophisticated digital instruments engineered for the appraisal of cognitive capabilities through established testing methodologies, encompassing memory functions, attentional processes, and problem-solving proficiencies. Illustratively, in April of 2024, BrainCheck Inc., a United States-headquartered digital health enterprise dedicated to fostering positive advancements in cognitive health, introduced its all-encompassing digital cognitive assessment framework at the American Academy of Neurology (AAN) Annual Meeting, thereby exhibiting its cutting-edge instruments designated for cognitive screening, thorough assessment, and strategic care design. This particular platform, comprising modules for Assessment, Screening, and Planning, provides healthcare professionals with a contemporary approach to optimizing the management of cognitive health, utilizing mobile technology that guarantees both accuracy and user-friendliness. Such groundbreaking developments are intended to bolster the operational efficiency and the caliber of healthcare services offered to both patients and practitioners by furnishing detailed, research-supported guidance and thorough strategies for patient care.

Cognitive Diagnostics Market Leading Companies Driving Competitive Growth

Major companies operating in the cognitive diagnostics market are Cogstate Ltd., Viz.ai, Redcliffe Labs, Mind Maze, Neurocare Group AG, Pathway Genomics, Diadem srl, Cambridge Cognition Ltd., Posit Science Corporation, Anderson Diagnostics & Labs. , Altoida AG, BrainScope Company Inc., Neurotrack Technologies Inc., Cognetivity Neurosciences Ltd., BrainCheck, Cyclops MedTech Pvt Ltd, Twill Inc., CN Diagnostics, Savonix Inc., Cognivue Inc., NeuroCog Trials, Pearson Clinical, Re:Cognition Health, CogniSense, The Neuropsychology Consultants

Access The Complete Cognitive Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report

Cognitive Diagnostics Market Largest Region By Revenue And Market Share

North Americawas the largest region in the cognitive diagnostics market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the cognitive diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Cognitive Diagnostics Market Size Forecast: How Large Could The Market Become By 2030?

The cognitive diagnostics market has experienced substantial expansion, with projections indicating a rise from a valuation of $6.25 billion in 2025 to $7.69 billion by 2026, reflecting a commanding compound annual growth rate of 23.1%. This remarkable growth trajectory has been propelled by several key factors, including the escalating incidence of neurodegenerative diseases, a heightened societal focus on maintaining cognitive well-being, advancements in diagnostic imaging technologies, the increasing utilization of uniform cognitive assessment tools, and the proliferation of specialized neurology clinics.

In the realm of cognitive diagnostics, a period of substantial expansion is anticipated in the ensuing years, with the market poised to reach a valuation of $17.46 billion by the year 2030. This impressive trajectory is underpinned by a compound annual growth rate (CAGR) of 22.7%, propelled by several key factors including escalating investments directed towards digital diagnostic solutions, a heightened demand for the identification of cognitive disorders in their nascent stages, the proliferation of assessment tools designed for at-home use, the increasing incorporation of artificial intelligence into clinical decision-making processes, and a pronounced emphasis on tailored cognitive care strategies. Furthermore, prevailing trends shaping this forecast period encompass the growing utilization of AI-powered cognitive assessment instruments, the wider adoption of digital platforms for cognitive screening, a greater deployment of neuroimaging analytics, the expansion of remote cognitive testing capabilities, and an intensified focus on the early detection of diseases.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19373&type=smp

#Cognitive Diagnostics Market Growth Drivers And Industry Catalysts

The burgeoning rates of neurological conditions are poised to act as a significant catalyst for the expansion of the cognitive diagnostics market. These neurological conditions, which impact the brain, spinal cord, and the broader nervous system, lead to functional impairments manifesting as cognitive deterioration, difficulties with motor control, and unusual sensory experiences. A primary factor fueling this increase is the higher occurrence of age-associated ailments, notably Alzheimer’s and Parkinson’s disease. In addition to genetic predispositions, environmental pollutants, elevated stress levels, poor dietary habits, and inactive lifestyles also play a role in the growing prevalence of these disorders. Within the realm of neurological diseases, cognitive diagnostics serve a crucial role in evaluating, identifying, and tracking impairments in cognitive function, thereby facilitating early detection and effective management of conditions such as Alzheimer’s and Parkinson’s. Illustratively, the Alzheimer’s Association, a U.S. nonprofit supporting Alzheimer’s care, assistance, and research, reported in May 2024 that the count of Americans aged 65 and over living with Alzheimer’s dementia climbed from 6.5 million in 2022 to an estimated 6.9 million in 2024. Consequently, the escalating incidence of neurological disorders is directly fostering the growth of the cognitive diagnostics market.

Cognitive Diagnostics Market Segment Analysis: What Are The Major Market Categories?

The cognitive diagnostics market covered in this report is segmented –

1) By Diagnosis: Brain Imaging Tests, Laboratory Testing, Mental Status Testing, Rapid Home Screening Tests, Neuropsychological Testing, Electroencephalogram (EEG), Cognitive Function And Behavioral Tests, Neuropsychiatric Inventory Questionnaire (NPI-Q)

2) By Indication: Alzheimer’s Disease, Attention Deficit Or Hyperactivity Disorder, Dementia, Epilepsy-Related Cognitive Dysfunction, Mild Cognitive Impairment, Parkinson’s Disease-Related Cognitive Dysfunction, Stroke-Related Cognitive Dysfunction, Traumatic Brain Injury, Other Indications

3) By End User: Hospitals, Neurology Clinics, Cognitive Behavioral Therapy Centers, Rehabilitation Centers, Academic And Research Institutes, Diagnostic Imaging Centers, Home Care Settings

Subsegments:

1) By Brain Imaging Tests: Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Computed Tomography (CT) Scans, Functional MRI (fMRI), Single-Photon Emission Computed Tomography (SPECT), Magnetoencephalography (MEG)

2) By Laboratory Testing: Blood Biomarkers for Cognitive Disorders, Genetic Testing for Cognitive Impairment, CSF (Cerebrospinal Fluid) Biomarker Tests, Hormonal and Metabolic Testing, Genetic Sequencing for Alzheimer’s Disease

3) By Mental Status Testing: Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Saint Louis University Mental Status (SLUMS) Exam, Cognitive Assessment Screening Tools

4) By Rapid Home Screening Tests: Self-Administered Cognitive Tests, Mobile App-Based Cognitive Screening, At-Home Memory and Mental Health Tests

5) By Neuropsychological Testing: Cognitive and Behavioral Assessment Batteries, Attention and Memory Function Tests, Executive Function and Problem-Solving Tests, Verbal and Visual Learning Tests

6) By Electroencephalogram (EEG): Resting-State EEG for Cognitive Disorders, Event-Related Potential (ERP) Testing, Quantitative EEG (QEEG) for Brain Mapping, Long-Term EEG Monitoring for Cognitive Disorders

7) By Cognitive Function and Behavioral Tests: Memory Function Tests, Attention and Concentration Tests, Language and Communication Tests, Mood and Behavior Assessments

8) By Neuropsychiatric Inventory Questionnaire (NPI-Q): NPI-Q for Dementia Screening, Behavioral and Psychological Symptoms of Dementia (BPSD) Assessment, NPI-Q for Alzheimer’s Disease and Other Cognitive Disorders, Shortened Versions of NPI-Q for Clinical Settings.

#Cognitive Diagnostics Market Trends Influencing Long-Term Demand

Leading entities within the cognitive diagnostics sector are prioritizing the delivery of immediate understandings of cognitive well-being, leveraging innovations in diagnostic instruments like neuropsychological testing platforms to elevate the precision, effectiveness, and completeness of cognitive evaluations. These advanced neuropsychological testing platforms serve as sophisticated digital instruments engineered for the appraisal of cognitive capabilities through established testing methodologies, encompassing memory functions, attentional processes, and problem-solving proficiencies. Illustratively, in April of 2024, BrainCheck Inc., a United States-headquartered digital health enterprise dedicated to fostering positive advancements in cognitive health, introduced its all-encompassing digital cognitive assessment framework at the American Academy of Neurology (AAN) Annual Meeting, thereby exhibiting its cutting-edge instruments designated for cognitive screening, thorough assessment, and strategic care design. This particular platform, comprising modules for Assessment, Screening, and Planning, provides healthcare professionals with a contemporary approach to optimizing the management of cognitive health, utilizing mobile technology that guarantees both accuracy and user-friendliness. Such groundbreaking developments are intended to bolster the operational efficiency and the caliber of healthcare services offered to both patients and practitioners by furnishing detailed, research-supported guidance and thorough strategies for patient care.

Cognitive Diagnostics Market Leading Companies Driving Competitive Growth

Major companies operating in the cognitive diagnostics market are Cogstate Ltd., Viz.ai, Redcliffe Labs, Mind Maze, Neurocare Group AG, Pathway Genomics, Diadem srl, Cambridge Cognition Ltd., Posit Science Corporation, Anderson Diagnostics & Labs. , Altoida AG, BrainScope Company Inc., Neurotrack Technologies Inc., Cognetivity Neurosciences Ltd., BrainCheck, Cyclops MedTech Pvt Ltd, Twill Inc., CN Diagnostics, Savonix Inc., Cognivue Inc., NeuroCog Trials, Pearson Clinical, Re:Cognition Health, CogniSense, The Neuropsychology Consultants

Access The Complete Cognitive Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report

Cognitive Diagnostics Market Largest Region By Revenue And Market Share

North Americawas the largest region in the cognitive diagnostics market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the cognitive diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Cognitive Diagnostics Market Size Forecast: How Large Could The Market Become By 2030?

The cognitive diagnostics market has experienced substantial expansion, with projections indicating a rise from a valuation of $6.25 billion in 2025 to $7.69 billion by 2026, reflecting a commanding compound annual growth rate of 23.1%. This remarkable growth trajectory has been propelled by several key factors, including the escalating incidence of neurodegenerative diseases, a heightened societal focus on maintaining cognitive well-being, advancements in diagnostic imaging technologies, the increasing utilization of uniform cognitive assessment tools, and the proliferation of specialized neurology clinics.

In the realm of cognitive diagnostics, a period of substantial expansion is anticipated in the ensuing years, with the market poised to reach a valuation of $17.46 billion by the year 2030. This impressive trajectory is underpinned by a compound annual growth rate (CAGR) of 22.7%, propelled by several key factors including escalating investments directed towards digital diagnostic solutions, a heightened demand for the identification of cognitive disorders in their nascent stages, the proliferation of assessment tools designed for at-home use, the increasing incorporation of artificial intelligence into clinical decision-making processes, and a pronounced emphasis on tailored cognitive care strategies. Furthermore, prevailing trends shaping this forecast period encompass the growing utilization of AI-powered cognitive assessment instruments, the wider adoption of digital platforms for cognitive screening, a greater deployment of neuroimaging analytics, the expansion of remote cognitive testing capabilities, and an intensified focus on the early detection of diseases.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19373&type=smp

#Cognitive Diagnostics Market Growth Drivers And Industry Catalysts

The burgeoning rates of neurological conditions are poised to act as a significant catalyst for the expansion of the cognitive diagnostics market. These neurological conditions, which impact the brain, spinal cord, and the broader nervous system, lead to functional impairments manifesting as cognitive deterioration, difficulties with motor control, and unusual sensory experiences. A primary factor fueling this increase is the higher occurrence of age-associated ailments, notably Alzheimer’s and Parkinson’s disease. In addition to genetic predispositions, environmental pollutants, elevated stress levels, poor dietary habits, and inactive lifestyles also play a role in the growing prevalence of these disorders. Within the realm of neurological diseases, cognitive diagnostics serve a crucial role in evaluating, identifying, and tracking impairments in cognitive function, thereby facilitating early detection and effective management of conditions such as Alzheimer’s and Parkinson’s. Illustratively, the Alzheimer’s Association, a U.S. nonprofit supporting Alzheimer’s care, assistance, and research, reported in May 2024 that the count of Americans aged 65 and over living with Alzheimer’s dementia climbed from 6.5 million in 2022 to an estimated 6.9 million in 2024. Consequently, the escalating incidence of neurological disorders is directly fostering the growth of the cognitive diagnostics market.

Cognitive Diagnostics Market Segment Analysis: What Are The Major Market Categories?

The cognitive diagnostics market covered in this report is segmented –

1) By Diagnosis: Brain Imaging Tests, Laboratory Testing, Mental Status Testing, Rapid Home Screening Tests, Neuropsychological Testing, Electroencephalogram (EEG), Cognitive Function And Behavioral Tests, Neuropsychiatric Inventory Questionnaire (NPI-Q)

2) By Indication: Alzheimer’s Disease, Attention Deficit Or Hyperactivity Disorder, Dementia, Epilepsy-Related Cognitive Dysfunction, Mild Cognitive Impairment, Parkinson’s Disease-Related Cognitive Dysfunction, Stroke-Related Cognitive Dysfunction, Traumatic Brain Injury, Other Indications

3) By End User: Hospitals, Neurology Clinics, Cognitive Behavioral Therapy Centers, Rehabilitation Centers, Academic And Research Institutes, Diagnostic Imaging Centers, Home Care Settings

Subsegments:

1) By Brain Imaging Tests: Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Computed Tomography (CT) Scans, Functional MRI (fMRI), Single-Photon Emission Computed Tomography (SPECT), Magnetoencephalography (MEG)

2) By Laboratory Testing: Blood Biomarkers for Cognitive Disorders, Genetic Testing for Cognitive Impairment, CSF (Cerebrospinal Fluid) Biomarker Tests, Hormonal and Metabolic Testing, Genetic Sequencing for Alzheimer’s Disease

3) By Mental Status Testing: Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Saint Louis University Mental Status (SLUMS) Exam, Cognitive Assessment Screening Tools

4) By Rapid Home Screening Tests: Self-Administered Cognitive Tests, Mobile App-Based Cognitive Screening, At-Home Memory and Mental Health Tests

5) By Neuropsychological Testing: Cognitive and Behavioral Assessment Batteries, Attention and Memory Function Tests, Executive Function and Problem-Solving Tests, Verbal and Visual Learning Tests

6) By Electroencephalogram (EEG): Resting-State EEG for Cognitive Disorders, Event-Related Potential (ERP) Testing, Quantitative EEG (QEEG) for Brain Mapping, Long-Term EEG Monitoring for Cognitive Disorders

7) By Cognitive Function and Behavioral Tests: Memory Function Tests, Attention and Concentration Tests, Language and Communication Tests, Mood and Behavior Assessments

8) By Neuropsychiatric Inventory Questionnaire (NPI-Q): NPI-Q for Dementia Screening, Behavioral and Psychological Symptoms of Dementia (BPSD) Assessment, NPI-Q for Alzheimer’s Disease and Other Cognitive Disorders, Shortened Versions of NPI-Q for Clinical Settings.

#Cognitive Diagnostics Market Trends Influencing Long-Term Demand

Leading entities within the cognitive diagnostics sector are prioritizing the delivery of immediate understandings of cognitive well-being, leveraging innovations in diagnostic instruments like neuropsychological testing platforms to elevate the precision, effectiveness, and completeness of cognitive evaluations. These advanced neuropsychological testing platforms serve as sophisticated digital instruments engineered for the appraisal of cognitive capabilities through established testing methodologies, encompassing memory functions, attentional processes, and problem-solving proficiencies. Illustratively, in April of 2024, BrainCheck Inc., a United States-headquartered digital health enterprise dedicated to fostering positive advancements in cognitive health, introduced its all-encompassing digital cognitive assessment framework at the American Academy of Neurology (AAN) Annual Meeting, thereby exhibiting its cutting-edge instruments designated for cognitive screening, thorough assessment, and strategic care design. This particular platform, comprising modules for Assessment, Screening, and Planning, provides healthcare professionals with a contemporary approach to optimizing the management of cognitive health, utilizing mobile technology that guarantees both accuracy and user-friendliness. Such groundbreaking developments are intended to bolster the operational efficiency and the caliber of healthcare services offered to both patients and practitioners by furnishing detailed, research-supported guidance and thorough strategies for patient care.

Cognitive Diagnostics Market Leading Companies Driving Competitive Growth

Major companies operating in the cognitive diagnostics market are Cogstate Ltd., Viz.ai, Redcliffe Labs, Mind Maze, Neurocare Group AG, Pathway Genomics, Diadem srl, Cambridge Cognition Ltd., Posit Science Corporation, Anderson Diagnostics & Labs. , Altoida AG, BrainScope Company Inc., Neurotrack Technologies Inc., Cognetivity Neurosciences Ltd., BrainCheck, Cyclops MedTech Pvt Ltd, Twill Inc., CN Diagnostics, Savonix Inc., Cognivue Inc., NeuroCog Trials, Pearson Clinical, Re:Cognition Health, CogniSense, The Neuropsychology Consultants

Access The Complete Cognitive Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report

Cognitive Diagnostics Market Largest Region By Revenue And Market Share

North Americawas the largest region in the cognitive diagnostics market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the cognitive diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Cognitive Diagnostics Market During 2026–2030?

The cognitive diagnostics market size has experienced significant expansion in recent years. It is anticipated to increase from $6.25 billion in 2025 to $7.69 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 23.1%. The historical development can be linked to the rising prevalence of neurodegenerative disorders, heightened awareness of cognitive health, advancements in diagnostic imaging capabilities, increased adoption of standardized cognitive tests, and the expansion of neurology specialty clinics.

The cognitive diagnostics market is poised for substantial growth over the next few years. It is projected to expand to $17.46 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 22.7%. The expansion throughout the forecast period is fueled by escalating investments in digital diagnostics, an increasing need for early-stage cognitive disorder detection, the proliferation of home-based cognitive assessment tools, the growing incorporation of AI into clinical decision support, and a heightened emphasis on personalized cognitive care. Prominent trends anticipated in this period include the rising application of AI-based cognitive assessment instruments, greater adoption of digital cognitive screening platforms, the expanding deployment of neuroimaging analytics, the widespread availability of remote cognitive testing solutions, and a reinforced focus on early disease detection.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report

What Leading Drivers Are Supporting The Cognitive Diagnostics Market Expansion?

The increasing occurrence of neurological conditions is anticipated to fuel expansion within the cognitive diagnostics market moving forward. These conditions, which impact the brain, spinal cord, and nervous system, hinder their proper functioning and manifest in symptoms like cognitive decline, motor impairment, and sensory issues. The surge in neurological disorders is largely attributable to a higher incidence of age-associated illnesses, including Alzheimer’s and Parkinson’s disease. Furthermore, genetic predispositions, alongside exposure to environmental toxins, stress, poor dietary habits, and inactive lifestyles, also contribute to their growing prevalence. Cognitive diagnostics play a crucial role in neurological diseases by evaluating, identifying, and tracking cognitive deficits, thereby assisting in the prompt diagnosis and management of conditions such as Alzheimer’s and Parkinson’s disease. For instance, in May 2024, a report from the Alzheimer’s Association, a U.S.-based nonprofit organization focused on Alzheimer’s care, support, and research, indicated that the count of Americans aged 65 and older diagnosed with Alzheimer’s dementia increased from 6.5 million in 2022 to an estimated 6.9 million in 2024. Consequently, the rising prevalence of neurological disorders is a key factor driving the growth of the cognitive diagnostics market.

What Are The Key Segment Divisions In The Cognitive Diagnostics Market Segment Structure?

The cognitive diagnostics market covered in this report is segmented –

1) By Diagnosis: Brain Imaging Tests, Laboratory Testing, Mental Status Testing, Rapid Home Screening Tests, Neuropsychological Testing, Electroencephalogram (EEG), Cognitive Function And Behavioral Tests, Neuropsychiatric Inventory Questionnaire (NPI-Q)

2) By Indication: Alzheimer’s Disease, Attention Deficit Or Hyperactivity Disorder, Dementia, Epilepsy-Related Cognitive Dysfunction, Mild Cognitive Impairment, Parkinson’s Disease-Related Cognitive Dysfunction, Stroke-Related Cognitive Dysfunction, Traumatic Brain Injury, Other Indications

3) By End User: Hospitals, Neurology Clinics, Cognitive Behavioral Therapy Centers, Rehabilitation Centers, Academic And Research Institutes, Diagnostic Imaging Centers, Home Care Settings

Subsegments:

1) By Brain Imaging Tests: Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Computed Tomography (CT) Scans, Functional MRI (fMRI), Single-Photon Emission Computed Tomography (SPECT), Magnetoencephalography (MEG)

2) By Laboratory Testing: Blood Biomarkers for Cognitive Disorders, Genetic Testing for Cognitive Impairment, CSF (Cerebrospinal Fluid) Biomarker Tests, Hormonal and Metabolic Testing, Genetic Sequencing for Alzheimer’s Disease

3) By Mental Status Testing: Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Saint Louis University Mental Status (SLUMS) Exam, Cognitive Assessment Screening Tools

4) By Rapid Home Screening Tests: Self-Administered Cognitive Tests, Mobile App-Based Cognitive Screening, At-Home Memory and Mental Health Tests

5) By Neuropsychological Testing: Cognitive and Behavioral Assessment Batteries, Attention and Memory Function Tests, Executive Function and Problem-Solving Tests, Verbal and Visual Learning Tests

6) By Electroencephalogram (EEG): Resting-State EEG for Cognitive Disorders, Event-Related Potential (ERP) Testing, Quantitative EEG (QEEG) for Brain Mapping, Long-Term EEG Monitoring for Cognitive Disorders

7) By Cognitive Function and Behavioral Tests: Memory Function Tests, Attention and Concentration Tests, Language and Communication Tests, Mood and Behavior Assessments

8) By Neuropsychiatric Inventory Questionnaire (NPI-Q): NPI-Q for Dementia Screening, Behavioral and Psychological Symptoms of Dementia (BPSD) Assessment, NPI-Q for Alzheimer’s Disease and Other Cognitive Disorders, Shortened Versions of NPI-Q for Clinical Settings.

What Emerging Trends Are Seen In The Cognitive Diagnostics Market?

Key companies operating in the cognitive diagnostics market are prioritizing real-time insights into cognitive health, propelled by technological advancements in diagnostic tools such as neuropsychological testing platforms, to heighten the accuracy, efficiency, and comprehensiveness of cognitive assessments. Neuropsychological testing platforms are specialized digital instruments created to evaluate cognitive functions through standardized tests, covering memory, attention, and problem-solving abilities. For instance, in April 2024, BrainCheck Inc., a US-based digital health company advancing cognitive health, launched its comprehensive digital cognitive assessment platform at the American Academy of Neurology (AAN) Annual Meeting, demonstrating its sophisticated tools for cognitive screening, assessment, and care planning. The platform, featuring Assess, Screen, and Plan, offers clinicians a contemporary solution to streamline cognitive health management with mobile, digital technology, ensuring precision and user-friendliness. This innovation aims to improve the efficiency and quality of care for patients and providers by delivering nuanced, evidence-based recommendations and thorough care planning.

Which Organizations Are Engaged In The Cognitive Diagnostics Market?

Major companies operating in the cognitive diagnostics market are Cogstate Ltd., Viz.ai, Redcliffe Labs, Mind Maze, Neurocare Group AG, Pathway Genomics, Diadem srl, Cambridge Cognition Ltd., Posit Science Corporation, Anderson Diagnostics & Labs. , Altoida AG, BrainScope Company Inc., Neurotrack Technologies Inc., Cognetivity Neurosciences Ltd., BrainCheck, Cyclops MedTech Pvt Ltd, Twill Inc., CN Diagnostics, Savonix Inc., Cognivue Inc., NeuroCog Trials, Pearson Clinical, Re:Cognition Health, CogniSense, The Neuropsychology Consultants

Get The Full Cognitive Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report

Which Region Dominates The Cognitive Diagnostics Market By Market Share?

North America was the largest region in the cognitive diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cognitive diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cognitive Diagnostics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report

Browse Through More Reports Similar to the Global Cognitive Diagnostics Market 2026, By The Business Research Company

Cognitive Process Automation Market Report 2026

https://www.thebusinessresearchcompany.com/report/cognitive-process-automation-global-market-report

Cognitive Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/cognitive-services-global-market-report

Cognitive Analytics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cognitive-analytics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Cognitive Diagnostics Market During 2026–2030?

The cognitive diagnostics market size has experienced significant expansion in recent years. It is anticipated to increase from $6.25 billion in 2025 to $7.69 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 23.1%. The historical development can be linked to the rising prevalence of neurodegenerative disorders, heightened awareness of cognitive health, advancements in diagnostic imaging capabilities, increased adoption of standardized cognitive tests, and the expansion of neurology specialty clinics.

The cognitive diagnostics market is poised for substantial growth over the next few years. It is projected to expand to $17.46 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 22.7%. The expansion throughout the forecast period is fueled by escalating investments in digital diagnostics, an increasing need for early-stage cognitive disorder detection, the proliferation of home-based cognitive assessment tools, the growing incorporation of AI into clinical decision support, and a heightened emphasis on personalized cognitive care. Prominent trends anticipated in this period include the rising application of AI-based cognitive assessment instruments, greater adoption of digital cognitive screening platforms, the expanding deployment of neuroimaging analytics, the widespread availability of remote cognitive testing solutions, and a reinforced focus on early disease detection.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report

What Leading Drivers Are Supporting The Cognitive Diagnostics Market Expansion?

The increasing occurrence of neurological conditions is anticipated to fuel expansion within the cognitive diagnostics market moving forward. These conditions, which impact the brain, spinal cord, and nervous system, hinder their proper functioning and manifest in symptoms like cognitive decline, motor impairment, and sensory issues. The surge in neurological disorders is largely attributable to a higher incidence of age-associated illnesses, including Alzheimer’s and Parkinson’s disease. Furthermore, genetic predispositions, alongside exposure to environmental toxins, stress, poor dietary habits, and inactive lifestyles, also contribute to their growing prevalence. Cognitive diagnostics play a crucial role in neurological diseases by evaluating, identifying, and tracking cognitive deficits, thereby assisting in the prompt diagnosis and management of conditions such as Alzheimer’s and Parkinson’s disease. For instance, in May 2024, a report from the Alzheimer’s Association, a U.S.-based nonprofit organization focused on Alzheimer’s care, support, and research, indicated that the count of Americans aged 65 and older diagnosed with Alzheimer’s dementia increased from 6.5 million in 2022 to an estimated 6.9 million in 2024. Consequently, the rising prevalence of neurological disorders is a key factor driving the growth of the cognitive diagnostics market.

What Are The Key Segment Divisions In The Cognitive Diagnostics Market Segment Structure?

The cognitive diagnostics market covered in this report is segmented –

1) By Diagnosis: Brain Imaging Tests, Laboratory Testing, Mental Status Testing, Rapid Home Screening Tests, Neuropsychological Testing, Electroencephalogram (EEG), Cognitive Function And Behavioral Tests, Neuropsychiatric Inventory Questionnaire (NPI-Q)

2) By Indication: Alzheimer’s Disease, Attention Deficit Or Hyperactivity Disorder, Dementia, Epilepsy-Related Cognitive Dysfunction, Mild Cognitive Impairment, Parkinson’s Disease-Related Cognitive Dysfunction, Stroke-Related Cognitive Dysfunction, Traumatic Brain Injury, Other Indications

3) By End User: Hospitals, Neurology Clinics, Cognitive Behavioral Therapy Centers, Rehabilitation Centers, Academic And Research Institutes, Diagnostic Imaging Centers, Home Care Settings

Subsegments:

1) By Brain Imaging Tests: Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Computed Tomography (CT) Scans, Functional MRI (fMRI), Single-Photon Emission Computed Tomography (SPECT), Magnetoencephalography (MEG)

2) By Laboratory Testing: Blood Biomarkers for Cognitive Disorders, Genetic Testing for Cognitive Impairment, CSF (Cerebrospinal Fluid) Biomarker Tests, Hormonal and Metabolic Testing, Genetic Sequencing for Alzheimer’s Disease

3) By Mental Status Testing: Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Saint Louis University Mental Status (SLUMS) Exam, Cognitive Assessment Screening Tools

4) By Rapid Home Screening Tests: Self-Administered Cognitive Tests, Mobile App-Based Cognitive Screening, At-Home Memory and Mental Health Tests

5) By Neuropsychological Testing: Cognitive and Behavioral Assessment Batteries, Attention and Memory Function Tests, Executive Function and Problem-Solving Tests, Verbal and Visual Learning Tests

6) By Electroencephalogram (EEG): Resting-State EEG for Cognitive Disorders, Event-Related Potential (ERP) Testing, Quantitative EEG (QEEG) for Brain Mapping, Long-Term EEG Monitoring for Cognitive Disorders

7) By Cognitive Function and Behavioral Tests: Memory Function Tests, Attention and Concentration Tests, Language and Communication Tests, Mood and Behavior Assessments

8) By Neuropsychiatric Inventory Questionnaire (NPI-Q): NPI-Q for Dementia Screening, Behavioral and Psychological Symptoms of Dementia (BPSD) Assessment, NPI-Q for Alzheimer’s Disease and Other Cognitive Disorders, Shortened Versions of NPI-Q for Clinical Settings.

What Emerging Trends Are Seen In The Cognitive Diagnostics Market?

Key companies operating in the cognitive diagnostics market are prioritizing real-time insights into cognitive health, propelled by technological advancements in diagnostic tools such as neuropsychological testing platforms, to heighten the accuracy, efficiency, and comprehensiveness of cognitive assessments. Neuropsychological testing platforms are specialized digital instruments created to evaluate cognitive functions through standardized tests, covering memory, attention, and problem-solving abilities. For instance, in April 2024, BrainCheck Inc., a US-based digital health company advancing cognitive health, launched its comprehensive digital cognitive assessment platform at the American Academy of Neurology (AAN) Annual Meeting, demonstrating its sophisticated tools for cognitive screening, assessment, and care planning. The platform, featuring Assess, Screen, and Plan, offers clinicians a contemporary solution to streamline cognitive health management with mobile, digital technology, ensuring precision and user-friendliness. This innovation aims to improve the efficiency and quality of care for patients and providers by delivering nuanced, evidence-based recommendations and thorough care planning.

Which Organizations Are Engaged In The Cognitive Diagnostics Market?

Major companies operating in the cognitive diagnostics market are Cogstate Ltd., Viz.ai, Redcliffe Labs, Mind Maze, Neurocare Group AG, Pathway Genomics, Diadem srl, Cambridge Cognition Ltd., Posit Science Corporation, Anderson Diagnostics & Labs. , Altoida AG, BrainScope Company Inc., Neurotrack Technologies Inc., Cognetivity Neurosciences Ltd., BrainCheck, Cyclops MedTech Pvt Ltd, Twill Inc., CN Diagnostics, Savonix Inc., Cognivue Inc., NeuroCog Trials, Pearson Clinical, Re:Cognition Health, CogniSense, The Neuropsychology Consultants

Get The Full Cognitive Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report

Which Region Dominates The Cognitive Diagnostics Market By Market Share?

North America was the largest region in the cognitive diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cognitive diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cognitive Diagnostics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report

Browse Through More Reports Similar to the Global Cognitive Diagnostics Market 2026, By The Business Research Company

Cognitive Process Automation Market Report 2026

https://www.thebusinessresearchcompany.com/report/cognitive-process-automation-global-market-report

Cognitive Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/cognitive-services-global-market-report

Cognitive Analytics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cognitive-analytics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Cognitive Diagnostics Market During 2026–2030?

The cognitive diagnostics market size has experienced significant expansion in recent years. It is anticipated to increase from $6.25 billion in 2025 to $7.69 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 23.1%. The historical development can be linked to the rising prevalence of neurodegenerative disorders, heightened awareness of cognitive health, advancements in diagnostic imaging capabilities, increased adoption of standardized cognitive tests, and the expansion of neurology specialty clinics.

The cognitive diagnostics market is poised for substantial growth over the next few years. It is projected to expand to $17.46 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 22.7%. The expansion throughout the forecast period is fueled by escalating investments in digital diagnostics, an increasing need for early-stage cognitive disorder detection, the proliferation of home-based cognitive assessment tools, the growing incorporation of AI into clinical decision support, and a heightened emphasis on personalized cognitive care. Prominent trends anticipated in this period include the rising application of AI-based cognitive assessment instruments, greater adoption of digital cognitive screening platforms, the expanding deployment of neuroimaging analytics, the widespread availability of remote cognitive testing solutions, and a reinforced focus on early disease detection.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report

What Leading Drivers Are Supporting The Cognitive Diagnostics Market Expansion?

The increasing occurrence of neurological conditions is anticipated to fuel expansion within the cognitive diagnostics market moving forward. These conditions, which impact the brain, spinal cord, and nervous system, hinder their proper functioning and manifest in symptoms like cognitive decline, motor impairment, and sensory issues. The surge in neurological disorders is largely attributable to a higher incidence of age-associated illnesses, including Alzheimer’s and Parkinson’s disease. Furthermore, genetic predispositions, alongside exposure to environmental toxins, stress, poor dietary habits, and inactive lifestyles, also contribute to their growing prevalence. Cognitive diagnostics play a crucial role in neurological diseases by evaluating, identifying, and tracking cognitive deficits, thereby assisting in the prompt diagnosis and management of conditions such as Alzheimer’s and Parkinson’s disease. For instance, in May 2024, a report from the Alzheimer’s Association, a U.S.-based nonprofit organization focused on Alzheimer’s care, support, and research, indicated that the count of Americans aged 65 and older diagnosed with Alzheimer’s dementia increased from 6.5 million in 2022 to an estimated 6.9 million in 2024. Consequently, the rising prevalence of neurological disorders is a key factor driving the growth of the cognitive diagnostics market.

What Are The Key Segment Divisions In The Cognitive Diagnostics Market Segment Structure?

The cognitive diagnostics market covered in this report is segmented –

1) By Diagnosis: Brain Imaging Tests, Laboratory Testing, Mental Status Testing, Rapid Home Screening Tests, Neuropsychological Testing, Electroencephalogram (EEG), Cognitive Function And Behavioral Tests, Neuropsychiatric Inventory Questionnaire (NPI-Q)

2) By Indication: Alzheimer’s Disease, Attention Deficit Or Hyperactivity Disorder, Dementia, Epilepsy-Related Cognitive Dysfunction, Mild Cognitive Impairment, Parkinson’s Disease-Related Cognitive Dysfunction, Stroke-Related Cognitive Dysfunction, Traumatic Brain Injury, Other Indications

3) By End User: Hospitals, Neurology Clinics, Cognitive Behavioral Therapy Centers, Rehabilitation Centers, Academic And Research Institutes, Diagnostic Imaging Centers, Home Care Settings

Subsegments:

1) By Brain Imaging Tests: Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Computed Tomography (CT) Scans, Functional MRI (fMRI), Single-Photon Emission Computed Tomography (SPECT), Magnetoencephalography (MEG)

2) By Laboratory Testing: Blood Biomarkers for Cognitive Disorders, Genetic Testing for Cognitive Impairment, CSF (Cerebrospinal Fluid) Biomarker Tests, Hormonal and Metabolic Testing, Genetic Sequencing for Alzheimer’s Disease

3) By Mental Status Testing: Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Saint Louis University Mental Status (SLUMS) Exam, Cognitive Assessment Screening Tools

4) By Rapid Home Screening Tests: Self-Administered Cognitive Tests, Mobile App-Based Cognitive Screening, At-Home Memory and Mental Health Tests

5) By Neuropsychological Testing: Cognitive and Behavioral Assessment Batteries, Attention and Memory Function Tests, Executive Function and Problem-Solving Tests, Verbal and Visual Learning Tests

6) By Electroencephalogram (EEG): Resting-State EEG for Cognitive Disorders, Event-Related Potential (ERP) Testing, Quantitative EEG (QEEG) for Brain Mapping, Long-Term EEG Monitoring for Cognitive Disorders

7) By Cognitive Function and Behavioral Tests: Memory Function Tests, Attention and Concentration Tests, Language and Communication Tests, Mood and Behavior Assessments

8) By Neuropsychiatric Inventory Questionnaire (NPI-Q): NPI-Q for Dementia Screening, Behavioral and Psychological Symptoms of Dementia (BPSD) Assessment, NPI-Q for Alzheimer’s Disease and Other Cognitive Disorders, Shortened Versions of NPI-Q for Clinical Settings.

What Emerging Trends Are Seen In The Cognitive Diagnostics Market?

Key companies operating in the cognitive diagnostics market are prioritizing real-time insights into cognitive health, propelled by technological advancements in diagnostic tools such as neuropsychological testing platforms, to heighten the accuracy, efficiency, and comprehensiveness of cognitive assessments. Neuropsychological testing platforms are specialized digital instruments created to evaluate cognitive functions through standardized tests, covering memory, attention, and problem-solving abilities. For instance, in April 2024, BrainCheck Inc., a US-based digital health company advancing cognitive health, launched its comprehensive digital cognitive assessment platform at the American Academy of Neurology (AAN) Annual Meeting, demonstrating its sophisticated tools for cognitive screening, assessment, and care planning. The platform, featuring Assess, Screen, and Plan, offers clinicians a contemporary solution to streamline cognitive health management with mobile, digital technology, ensuring precision and user-friendliness. This innovation aims to improve the efficiency and quality of care for patients and providers by delivering nuanced, evidence-based recommendations and thorough care planning.

Which Organizations Are Engaged In The Cognitive Diagnostics Market?

Major companies operating in the cognitive diagnostics market are Cogstate Ltd., Viz.ai, Redcliffe Labs, Mind Maze, Neurocare Group AG, Pathway Genomics, Diadem srl, Cambridge Cognition Ltd., Posit Science Corporation, Anderson Diagnostics & Labs. , Altoida AG, BrainScope Company Inc., Neurotrack Technologies Inc., Cognetivity Neurosciences Ltd., BrainCheck, Cyclops MedTech Pvt Ltd, Twill Inc., CN Diagnostics, Savonix Inc., Cognivue Inc., NeuroCog Trials, Pearson Clinical, Re:Cognition Health, CogniSense, The Neuropsychology Consultants

Get The Full Cognitive Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report

Which Region Dominates The Cognitive Diagnostics Market By Market Share?

North America was the largest region in the cognitive diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cognitive diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cognitive Diagnostics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report

Browse Through More Reports Similar to the Global Cognitive Diagnostics Market 2026, By The Business Research Company

Cognitive Process Automation Market Report 2026

https://www.thebusinessresearchcompany.com/report/cognitive-process-automation-global-market-report

Cognitive Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/cognitive-services-global-market-report

Cognitive Analytics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cognitive-analytics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Cognitive Diagnostics Market At The End Of The 2026–2030 Forecast Period?

The cognitive diagnostics market has seen substantial expansion in recent years. It is anticipated to increase from $6.25 billion in 2025 to $7.69 billion in 2026, achieving a compound annual growth rate (CAGR) of 23.1%. The growth observed in the historic period stems from the growing prevalence of neurodegenerative disorders, increasing awareness of cognitive health, expansion of diagnostic imaging capabilities, rising adoption of standardized cognitive tests, and growth in neurology specialty clinics.

The cognitive diagnostics market is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $17.46 billion by 2030, achieving a compound annual growth rate (CAGR) of 22.7%. This expansion during the forecast period can be attributed to increased investments in digital diagnostics, a heightened demand for early-stage cognitive disorder detection, the proliferation of home-based cognitive assessment tools, the growing integration of AI in clinical decision support, and an increasing focus on personalized cognitive care. Key trends for the forecast period include the rising use of AI-based cognitive assessment tools, greater adoption of digital cognitive screening platforms, the expanding deployment of neuroimaging analytics, the broadening of remote cognitive testing solutions, and an enhanced emphasis on early disease detection.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19373&type=smp

What Drivers Are Shaping The Future Growth Of The Cognitive Diagnostics Market?

A projected increase in neurological disorder cases is anticipated to drive expansion in the cognitive diagnostics market in the future. These medical conditions impact the brain, spinal cord, and nervous system, hindering their normal operation and resulting in manifestations like diminished cognitive function, motor skill impairment, and sensory irregularities. The growing occurrence of neurological disorders stems from a higher incidence of age-associated ailments including Alzheimer’s and Parkinson’s disease. Additionally, genetic predispositions, environmental pollutants, psychological stress, poor dietary habits, and inactive lifestyles also play a role in the rising frequency of these conditions. Within the context of neurological diseases, cognitive diagnostics serve to evaluate, identify, and track cognitive deficits, facilitating prompt identification and treatment of diseases such as Alzheimer’s and Parkinson’s. As an illustration, a May 2024 report from the Alzheimer’s Association, a U.S.-based non-profit focused on Alzheimer’s care, support, and research, indicated that individuals in America aged 65 and above diagnosed with Alzheimer’s dementia increased from 6.5 million in 2022 to an estimated 6.9 million by 2024. Consequently, the increasing occurrence of neurological disorders is fueling the expansion of the cognitive diagnostics market.

What Segment Types Make Up The Cognitive Diagnostics Market?

The cognitive diagnostics market covered in this report is segmented –

1) By Diagnosis: Brain Imaging Tests, Laboratory Testing, Mental Status Testing, Rapid Home Screening Tests, Neuropsychological Testing, Electroencephalogram (EEG), Cognitive Function And Behavioral Tests, Neuropsychiatric Inventory Questionnaire (NPI-Q)

2) By Indication: Alzheimer’s Disease, Attention Deficit Or Hyperactivity Disorder, Dementia, Epilepsy-Related Cognitive Dysfunction, Mild Cognitive Impairment, Parkinson’s Disease-Related Cognitive Dysfunction, Stroke-Related Cognitive Dysfunction, Traumatic Brain Injury, Other Indications

3) By End User: Hospitals, Neurology Clinics, Cognitive Behavioral Therapy Centers, Rehabilitation Centers, Academic And Research Institutes, Diagnostic Imaging Centers, Home Care Settings

Subsegments:

1) By Brain Imaging Tests: Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Computed Tomography (CT) Scans, Functional MRI (fMRI), Single-Photon Emission Computed Tomography (SPECT), Magnetoencephalography (MEG)

2) By Laboratory Testing: Blood Biomarkers for Cognitive Disorders, Genetic Testing for Cognitive Impairment, CSF (Cerebrospinal Fluid) Biomarker Tests, Hormonal and Metabolic Testing, Genetic Sequencing for Alzheimer’s Disease

3) By Mental Status Testing: Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Saint Louis University Mental Status (SLUMS) Exam, Cognitive Assessment Screening Tools

4) By Rapid Home Screening Tests: Self-Administered Cognitive Tests, Mobile App-Based Cognitive Screening, At-Home Memory and Mental Health Tests

5) By Neuropsychological Testing: Cognitive and Behavioral Assessment Batteries, Attention and Memory Function Tests, Executive Function and Problem-Solving Tests, Verbal and Visual Learning Tests

6) By Electroencephalogram (EEG): Resting-State EEG for Cognitive Disorders, Event-Related Potential (ERP) Testing, Quantitative EEG (QEEG) for Brain Mapping, Long-Term EEG Monitoring for Cognitive Disorders

7) By Cognitive Function and Behavioral Tests: Memory Function Tests, Attention and Concentration Tests, Language and Communication Tests, Mood and Behavior Assessments

8) By Neuropsychiatric Inventory Questionnaire (NPI-Q): NPI-Q for Dementia Screening, Behavioral and Psychological Symptoms of Dementia (BPSD) Assessment, NPI-Q for Alzheimer’s Disease and Other Cognitive Disorders, Shortened Versions of NPI-Q for Clinical Settings.

What Key Developments And Trends Are Impacting The Cognitive Diagnostics Market?

Leading companies in the cognitive diagnostics market are concentrating on generating real-time insights into cognitive health through technological advancements in diagnostic tools, particularly neuropsychological testing platforms, to improve the accuracy, efficiency, and completeness of cognitive evaluations. Neuropsychological testing platforms are specialized digital instruments designed to evaluate cognitive functions via standardized tests, covering areas such as memory, attention, and problem-solving skills. For instance, in April 2024, BrainCheck Inc., a US-based digital health company driving positive progress in cognitive health, launched its comprehensive digital cognitive assessment platform at the American Academy of Neurology (AAN) Annual Meeting, demonstrating its advanced tools for cognitive screening, assessment, and care planning. The platform, which includes Assess, Screen, and Plan, furnishes clinicians with a contemporary solution to streamline cognitive health management using mobile, digital technology that ensures accuracy and ease of operation. This innovation aims to elevate the efficiency and quality of care for patients and providers by furnishing nuanced, evidence-based recommendations and thorough care planning.

Who Are The Key Players Driving Competition In The Cognitive Diagnostics Market?

Major companies operating in the cognitive diagnostics market are Cogstate Ltd., Viz.ai, Redcliffe Labs, Mind Maze, Neurocare Group AG, Pathway Genomics, Diadem srl, Cambridge Cognition Ltd., Posit Science Corporation, Anderson Diagnostics & Labs. , Altoida AG, BrainScope Company Inc., Neurotrack Technologies Inc., Cognetivity Neurosciences Ltd., BrainCheck, Cyclops MedTech Pvt Ltd, Twill Inc., CN Diagnostics, Savonix Inc., Cognivue Inc., NeuroCog Trials, Pearson Clinical, Re:Cognition Health, CogniSense, The Neuropsychology Consultants

Read the full cognitive diagnostics market report here:

https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report

Which Geographic Regions Are Influencing Demand In The Cognitive Diagnostics Market?

North America was the largest region in the cognitive diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cognitive diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cognitive Diagnostics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19373&type=smp

Browse Through More Reports Similar to the Global Cognitive Diagnostics Market 2026, By The Business Research Company

Behavioral Therapy Global Market Report

https://www.thebusinessresearchcompany.com/report/behavioral-therapy-global-market-report

Behavioral Rehabilitation Global Market Report

https://www.thebusinessresearchcompany.com/report/behavioral-rehabilitation-global-market-report

Behavioral And Mental Health Software Global Market Report

https://www.thebusinessresearchcompany.com/report/behavioral-and-mental-health-software-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model